Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial.
暂无分享，去创建一个
D. Grobbee | L. Rydén | J. Tardif | K. Malmberg | B. Neal | A. Lincoff | J. Buse | R. Henry | S. Nicholls | H. Wedel | D. Volz | G. Schwartz | R. Cannata | Anders Svensson | Arlette Weichert